Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Frost, Robert A ^a   Nystrom, Gerald J ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Dexamethasone; Interleukin; Toll like receptor 4; Tumor necrosis factor

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ANTIINFLAMMATORY AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYTOKINE; DEXAMETHASONE; I KAPPA B; I KAPPA B ALPHA; I KAPPA B EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEPTIDOGLYCAN; PROTEASOME INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HALF LIFE TIME; INFLAMMATION; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKELETAL MUSCLE;

EID: 0036724610     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00039.2002     Document Type: Article

References (46)

1. Bacterial lipopolysaccharides and innate immunity
2. TNF-α modulates cytokine and cytokine receptors in C2C12 myotubes
3. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
4. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: The role of toll-like receptor-4
5. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor κB-independent bone morphogenetic protein/Smad signaling
6. Regulation of skeletal muscle protein turnover during sepsis: Mechanisms and mediators
7. Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle
8. Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes
9. CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin
10. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation
11. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes
12. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor
13. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1
14. Proteasome blockers inhibit TNF-α release by lipopolysaccharide stimulated macrophages and microglia: Implications for HIV-1 dementia
15. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins
16. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
17. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis
18. Tumor necrosis factor induces skeletal muscle protein breakdown in rats
19. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor α mRNA
20. A Toll-like receptor recognizes bacterial DNA
21. Leucine metabolism in TNF-α- and endotoxin-treated rats: Contribution of hepatic tissue
22. Possible involvement of proteasomes (prosomes) in AUUUA-mediated mRNA decay
23. Critical roles of Toll-like receptors in host defense
24. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis
25. TNF-α impairs heart and skeletal muscle protein synthesis by altering translational initiation
26. mRNA and protein stability regulate the differential expression of pro- and antiinflammatory genes in endotoxin-tolerant THP-1 cells
27. Effect of tumor necrosis factor-α on skeletal muscle metabolism
28. TNF-α regulates early differentiation of C2C12 myoblasts in an autocrine fashion
29. Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-α and lymphotoxin
30. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage
31. Toll-like receptor family and signalling pathway
32. Interleukin-12 prevents diaphragm muscle deterioration in a septic animal model
33. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells
34. Cooperative induction of pro-inflammatory signaling by Toll-like receptors
35. Host resistance to infection: Genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes
36. Transcriptional and translational regulation of IL-1α and IL-1β account for the control of IL-1 in experimental yersiniosis
37. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion
38. Superinduction of interleukin-6 mRNA in lung epithelial H292 cells depends on transiently increased C/EBP activity and durable increased mRNA stability
39. The expression of TNF α by human muscle. Relationship to insulin resistance
40. TNF-α mRNA expression in diaphragm muscle after endotoxin administration
41. Glucocorticoids suppress tumor necrosis factor-α expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-κB and c-Jun-activating transcription factor-2 binding sites in the promoter
42. Shock and tissue injury induced by recombinant human cachectin
43. A CD14-independent LPS receptor cluster
44. Recognition of gram-negative bacteria and endotoxin by the innate immune system
45. Structural basis for recognition of AU-rich element RNA by the HuD protein
46. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains